ArticleThe Pediatric infectious disease journal2026
Linking Children and Adolescents With TB Disease to HIV Services in 16 PEPFAR-supported High TB/HIV-Burden Countries in Sub-Saharan Africa, October 2018-September 2022.
Article in The Pediatric infectious disease journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Funding
Abstract
introductionPromptly identifying children and adolescents living with both tuberculosis (TB) disease and human immunodeficiency virus (HIV) and ensuring they receive antiretroviral treatment (ART) can reduce TB/HIV-associated mortality. We reviewed linkage of children and young adolescents with TB to HIV services at clinical sites in 16 high TB/HIV-burden sub-Saharan African countries supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR).
methodsPEPFAR monitoring, evaluation and reporting data describing persons <15 years of age with TB disease during October 2018-September 2022 were reviewed. Indicators included known HIV status (proportion of clients with TB who have known HIV status), HIV positivity (proportion with TB and known HIV status who have HIV, including those newly identified and those already diagnosed with HIV) and ART linkage (proportion with TB/HIV coinfection who were receiving ART). Data were collected quarterly except for ART linkage (collected annually starting in October 2021). Trend performance of indicators during the 4-year period by quarter and annual performance, stratified by sex, age, geographic region and ART status in the final year are described.
resultsAmong children and adolescents <15 years old with TB during October 2018-September 2022, known HIV status quarterly coverage increased (90% [October-December 2018] to 91% [July-September 2022]); HIV positivity decreased (22%-14%), including newly positive (7%-4%); and ART coverage increased (90%-97%). In total, during October 2021-September 2022, among 73,183 children with TB, 93% (n = 67,968) had a known HIV status, of which 14% (9295/67,968) were positive (4% newly identified [2730/67,968] and 10% already diagnosed [6565/67,968]). Of 9295 with TB/HIV, 97% (9050/9295) were currently or newly started on ART. Known HIV status was lower among infants <1 year (74%, 4883/6605), and ART linkage was lower among children <1 (93%, 502/542) and 1-4 years of age (93%, 2791/2993).
conclusionsThese findings highlight effective PEPFAR-supported integration of HIV services into TB services; however, gaps among young children persist. While HIV positivity decreased among children and adolescents with TB, universal HIV testing of those with TB remains an important strategy to close pediatric HIV treatment gaps and reduce mortality in high-burden countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.